Launch — Access limited to 250 Members to ensure personalized follow-up quality.

hs-CRP (High-Sensitivity C-Reactive Protein)

Protéine C-réactive ultrasensible · CRP ultrasensible · CRP-us · Protéine C-réactive de haute sensibilité

Inflammation

Low-grade chronic inflammation silently accelerates biological aging. hs-CRP provides a precise reading window into this process, well before any clinical signal appears. Tracking this marker over time maps inflammatory balance and evaluates how lifestyle choices affect deep biology.

Last updated: April 2, 2026

Physiological Role

C-reactive protein (CRP) is synthesized by the liver in response to inflammatory signals. Its production rises in the presence of tissue injury, infection, or metabolic stress. hs-CRP is an ultra-sensitive assay that measures very low concentrations, where standard CRP only captures overt elevations.

CRP serves a dual biological role. It binds to damaged cells and cellular debris to facilitate their clearance. It also activates the complement system, a cascade of proteins involved in immune defense. This mechanism is essential during acute events. It becomes problematic when it persists at low levels.

Low-grade chronic inflammation is distinguished by its silent, prolonged nature. It produces no fever, pain, or visible redness. Yet the immune system remains in a state of permanent activation. Longevity research identifies this phenomenon as an accelerator of biological aging.

Reference Ranges

These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.

Optimal< 1 mg/L
Élevé1 – 3 mg/L
Très élevé> 3 mg/L

Source : AHA/CDC, CRP cutoffs for CVD risk (2003)

Biological Significance

An hs-CRP level in the optimal zone reflects a favorable inflammatory balance. Cohort studies associate this zone with a stable cardiovascular and metabolic profile. This is the most favorable scenario for long-term health.

Elevated values signal persistent inflammatory activation. The most common drivers include excess visceral adipose tissue, physical inactivity, smoking, and a pro-inflammatory diet. A persistently elevated hs-CRP warrants closer monitoring and discussion with a healthcare professional.

Very high values may reflect an active inflammatory process beyond low-grade inflammation. A recent infection, trauma, or acute episode can temporarily raise hs-CRP. The test gains reliability when repeated at a distance from any acute event.

hs-CRP interpretation is enriched when combined with other markers in the Singular panel. Ferritin, for example, rises during inflammatory states regardless of iron stores. Cross-referencing these two markers helps distinguish inflammation-driven ferritin elevation from a genuine iron excess.

Influencing Factors

Diet. A diet high in refined sugars, trans fats, and ultra-processed foods promotes chronic inflammatory activation. Conversely, a diet rich in vegetables, fiber, and omega-3 fatty acids is associated with lower hs-CRP levels.

Physical activity. Regular moderate-intensity exercise is one of the most documented levers for lowering hs-CRP. Studies observe a significant decrease after several weeks of sustained activity. A single bout of intense exercise may, however, raise hs-CRP temporarily.

Body composition. Visceral adipose tissue is a major production site for pro-inflammatory molecules. Abdominal fat mass is one of the strongest determinants of hs-CRP levels. Reducing visceral adiposity frequently helps bring values back toward the optimal zone.

Sleep. Insufficient or poor-quality sleep is associated with higher hs-CRP. Research on circadian rhythms shows that chronic sleep deprivation sustains a state of low-grade inflammation.

Smoking. Smoking is an independent factor for hs-CRP elevation. Quitting leads to a gradual decline in inflammatory levels over several months.

Chronic stress. Prolonged psychological stress activates the hypothalamic-pituitary-adrenal axis. Sustained activation increases cortisol production and promotes systemic low-grade inflammation. Stress management techniques are associated with improved inflammatory profiles.

Supplementation. Omega-3 (EPA+DHA), curcumin, taurine, and reishi are among the bioactives documented for their influence on inflammatory markers. Their inclusion in the Singular formula allows personalized adjustment based on the biological profile.

In the Singular Formula

hs-CRP plays a central role in the Singular formulation engine. It drives bioactive adjustments related to inflammatory balance and serves as a reading parameter for other panel markers.

When hs-CRP falls in the elevated or very elevated zone, the engine activates an inflammatory balance support protocol. Curcumin dosage is increased. Taurine and reishi also see their dosages raised. Omega-3 (EPA+DHA), whose contribution to normal heart function is documented, are integrated at a reinforced dosage.

hs-CRP also acts as a safeguard in iron personalization rules. Ferritin is an acute-phase protein that rises during inflammation, regardless of actual iron stores. The engine verifies that hs-CRP is in the optimal zone before increasing iron and vitamin C in response to low iron markers. This cross-check prevents inappropriate supplementation based on inflammation-biased values.

Beyond the ruleset, other formula bioactives are documented for their influence on inflammatory balance. Sulforaphane and N-acetylcysteine, a glutathione precursor, are supported by substantial literature in this area.

hs-CRP is read alongside several other Singular panel markers. Ferritin and transferrin saturation allow cross-referencing of inflammation and iron status. Homocysteine, HOMA-IR, and triglycerides complete the mapping of the metabolic and inflammatory profile.

Scientific Studies

AuthorsYearTypeJournal

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

Meta-analysis of 160,309 participants from 54 prospective studies. hs-CRP shows a log-linear association with coronary risk, stroke risk, and vascular mortality.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

CANTOS trial involving 10,061 participants. Targeted inflammation reduction (without lowering LDL) decreases hs-CRP and reduces recurrent cardiovascular events.

Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis

Meta-analysis of 14 studies including 83,995 participants. Elevated hs-CRP independently predicts all-cause and cardiovascular mortality risk.

Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials

Meta-analysis of 83 studies demonstrating that regular exercise significantly reduces hs-CRP, regardless of training type.

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis

Meta-analysis of six randomized controlled trials showing a significant CRP reduction following curcumin supplementation.

Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis

Umbrella meta-analysis confirming the efficacy of omega-3 supplementation in reducing inflammatory biomarkers, including CRP.

Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials

Systematic review and dose-response meta-analysis showing that taurine supplementation significantly reduces CRP and other inflammatory markers.

Frequently Asked Questions

The information on this page is provided for informational and educational purposes only. It does not constitute medical advice and is not a substitute for consultation with a healthcare professional.

hs-CRP: Understanding Chronic Low-Grade Inflammation | Singular